Rob J.M. de Vries

Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

Rob J.M. de Vries, Dirk J. van Veldhuisen, Peter H.J.M. Dunselman · American Heart Journal · 2000 · 57 citations

Medicine, Cardiology, Pharmacology +14

Long-Term Anti-Ischemic Effects of Angiotensin-Converting Enzyme Inhibition in Patients After Myocardial Infarction fn1fn1This study was presented in part at the 46th Annual Scientific Session of the American College of Cardiology, Anaheim, California, March 1997 and was supported by a grant from Bristol Meyers Squibb, Woerden, The Netherlands.

Ad F.M. van den Heuvel, Wiek H. van Gilst, Dirk J. van Veldhuisen et al. · Journal of the American College of Cardiology · 1997 · 43 citations

Medicine, Cardiology, Pharmacology +15

Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure

Rob J.M. de Vries, Michel Quéré, Dirk J. Lok et al. · The American Journal of Cardiology · 1995 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +11

Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris

Rob J.M. de Vries, Ad F.M van den Heuvel, Dirk J. Lok et al. · International Journal of Cardiology · 1996 · 29 citations

Medicine, Cardiology, Pharmacology +9

Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients >65 years of age with angina pectoris

Rob J.M. de Vries, Peter H.J.M. Dunselman, Dirk J. van Veldhuisen et al. · The American Journal of Cardiology · 1994 · 19 citations

Medicine, Cardiology, Pharmacology +10